Clin2
NCT06710964Possibly a fitNot yet recruiting

Oxytocin and suicide risk study

Mechanistic Self-Dehumanization ConditionControl Condition

Treatments studied

This study looks at how a hormone called oxytocin affects feelings of self-worth and suicide risk. It involves a nasal spray and blood draws to measure oxytocin levels, and may help find new ways to support people who have had suicidal thoughts.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
50 people
Ages
18 years to 40 years
Study type
Interventional

Who can take part

  • You must be between 18 and 40 years old.
  • If you are a biological female, you need to have a regular menstrual cycle of 26 to 30 days.
  • You must have had suicidal thoughts at some point in your life.
  • You must have a certain level of feeling disconnected from your own humanity (self-dehumanization).
  • You cannot have a fear of needles.
  • You must be able to fast for 10 hours (water is allowed).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06713473Not yet recruiting
Oxytocin and suicide risk: a study for women with suicidal thoughts

This study tests whether a dose of oxytocin (a natural brain chemical) affects how you see yourself and whether that relates to suicide risk. You would visit the lab twice, fast for 10 hours before one visit, and get either oxytocin or a placebo.

Tallahassee, Florida
NCT04923685Recruiting
Study looks at blood markers linked to childhood trauma and suicide risk

This study checks whether tiny genetic signals in blood (microRNAs) are linked to childhood maltreatment and thoughts or risk of suicide, especially in people with major depression. It may help researchers understand biological clues that could someday guide better care.

Birmingham, Alabama
NCT06462196Recruiting
Study of Depression, Bipolar Disorder & Suicide Risk

This study looks at how depression, bipolar disorder, and suicide risk naturally change over time. It aims to better understand these conditions so doctors can improve treatments.

Bethesda, Maryland
NCT07551882Recruiting· Phase 2
Oxytocin and self-compassion training for borderline personality disorder

This study tests whether oxytocin (a hormone given as a nasal spray) combined with training in self-compassion can help people with borderline personality disorder, especially those who are very self-critical. You would receive the oxytocin spray and participate in self-compassion training sessions over several weeks.

Barcelona, Barcelona
NCT05765864Recruiting
Study of self-harm in at-risk teens

This study looks at self-harm and thoughts/behaviors related to safety in teenagers who are considered at higher risk. It may help researchers better understand what supports are needed for teens who self-harm without wanting to die.

Ljubljana
NCT03736538Enrolling by invitation· Phase 1
Nitrous oxide for suicidal thoughts in depression

This Phase 1 study tests whether breathing nitrous oxide can safely reduce suicidal thoughts in adults with major depression. It may help people whose depression is causing moderate to severe suicidal thinking, by studying a fast-acting treatment approach.

St Louis, Missouri

Hear when a new Control Condition trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.